European Drug Discovery Informatics Market Reaches $1,029.9 Million in 2025 with 6.7% CAGR

European drug discovery informatics market was valued at $1,029.9 million in 2025 and is projected to reach $1,967.4 million by 2035, growing at a CAGR of 6.7% during the forecast period (2026–2035). Drug discovery informatics refers to the use of computational tools, data platforms, and advanced analytics to support and accelerate drug development processes, including molecular modeling, virtual screening and docking, library and database preparation, sequencing, and target data analysis. The market is experiencing steady growth across Europe, supported by strong pharmaceutical and biotechnology research infrastructure, increasing R&D spending, and early adoption of digital and data-driven drug discovery approaches. Countries such as Germany, the United Kingdom, France, Switzerland, and the Netherlands are at the forefront, driven by the presence of leading pharmaceutical companies, academic research institutions, and well-established contract research organizations (CROs). In addition, EU-funded research initiatives and cross-border collaborative programs are playing a key role in strengthening regional capabilities in computational drug discovery.

Browse the full report description of “European Drug Discovery Informatics Market Size, Share & Trends Analysis Report by Function (Docking, Molecular Modeling, Libraries & Database Preparation, Sequencing & Target Data Analysis, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Others) Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/europe-drug-discovery-informatics-market

Key trends shaping the European drug discovery informatics landscape include the growing integration of artificial intelligence and machine learning for lead identification and optimization, increased use of cloud-based and high-performance computing platforms, and expanding utilization of large-scale chemical, genomic, and proteomic databases to improve efficiency and reduce drug development timelines.

According to According to NCBI and the UNESCO Institute, Europe is a major contributor to global drug discovery informatics through its extensive public biological databases, high volume of biomedical research output, and coordinated bioinformatics infrastructure. Public repositories and research infrastructures in Europe generate and curate large volumes of sequence data, protein structural data, and genomic/phenotypic datasets that support key informatics functions such as docking, molecular modeling, libraries & database preparation, and sequencing and target data analysis.

Key Innovators Driving European Drug Discovery Informatics Transformation

The key players in the European drug discovery informatics market include Dassault Systèmes SE, Eurofins Scientific SE, Evotec SE, PerkinElmer, Inc., Thermo Fisher Scientific Inc., among others. These companies are advancing innovation through integrated modeling and simulation platforms, AI-enabled analytics, and end-to-end informatics solutions, shaping the future of drug discovery and development across Europe.

• In November 2025, Merck KGaA signed a high-value agreement exceeding $3 billion with U.S.-based Valo Health to utilize Valo’s AI-driven drug discovery platforms for developing therapies targeting neurodegenerative disorders, including Parkinson’s disease. The collaboration highlights the increasing dependence of established European pharmaceutical companies on AI-powered informatics.
• In September 2025, Eli Lilly launched TuneLab, an AI and machine-learning–based drug discovery platform designed to make advanced predictive modeling accessible to smaller biotech companies and research organizations. Although Eli Lilly is headquartered in the United States, the launch has notable implications for the European informatics market by expanding access to cutting-edge tools and promoting wider adoption across global R&D networks

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Function
  • By End-Users
• Competitive Landscape - Dassault Systèmes SE, Eurofins Scientific SE, Evotec SE, PerkinElmer, Inc., Thermo Fisher Scientific Inc., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

European Drug Discovery Informatics Market Report Segment

By Function

• Docking
• Molecular Modeling
• Libraries & Database Preparation
• Sequencing & Target Data Analysis
• Others

By End-Users

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Others

European Drug Discovery Informatics Market Report Segment by Region

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/europe-drug-discovery-informatics-market